Third-Generation Direct Electron Transfer (DET)

Third-Generation Direct Electron Transfer (DET)

A third-generation glucose sensor tries to work without either helper the older designs depend on: oxygen in the first generation, and an artificial mediator molecule that ferries electrons in the second [1]. In direct electron transfer, or DET, electrons move straight from the enzyme's redox center to the electrode. For Glucose Oxidase, that redox center is a cofactor called flavin adenine dinucleotide (FAD) [3].

The hard part is distance. Electrons cross the gap by quantum tunneling, and efficient transfer needs the cofactor no more than about 2 nanometers (20 ångströms) from the electrode surface [2]. Glucose oxidase keeps its FAD sites buried, roughly 17 to 22 ångströms below the protein's outer surface [3]. That is why DET work leans on Nanotechnology. Groups have tried Carbon Nanotubes, and one well-known design rebuilt the enzyme around a Gold Nanoparticle about 1.4 nanometers across so the metal sat right next to the active site [3].

Here's what surprised us: whether native glucose oxidase does DET at all is still contested. A 2018 analysis by Bartlett and Al-Lolage concluded there is no evidence for it at carbon nanotubes or graphene [4]. Two reviews of the field agree that the redox signal many papers credit to DET most likely comes from FAD that has come loose from the enzyme and stuck to the electrode [2][3]. Other groups maintain the cofactor stays bound, so the question isn't settled [3].

DET offers key advantages:

• Superior selectivity. Without a mediator, the sensor can run at a voltage close to the enzyme's own redox potential, which cuts down on side reactions from other compounds in the sample [3]. Yoo and Lee also credit the missing mediator for this selectivity [1].
• Low voltages. An interferent is any substance that reacts at the electrode at the sensor's working voltage and donates electrons that didn't come from glucose, pushing the reading falsely high [1]. Acetaminophen is on the FDA's suggested list of standard interferents [1]. A lower working voltage means fewer of these compounds react, which reduces this kind of error rather than ruling it out [3].

However, DET faces challenges:

• Low current density, meaning a weak signal for each square millimeter of electrode. Only enzyme molecules that sit close enough to the surface, in the right orientation, can pass electrons directly [3]. A survey of DET enzymes found that only a fraction of the enzyme immobilized on an electrode is in direct communication with it [5]. Even the gold-nanoparticle design needed a large extra voltage before its glucose current appeared, giving back part of the low-voltage advantage [3].
• Cost and scale. Bollella and Katz describe the modified electrodes behind most DET results as costly and complex to prepare, which so far keeps them from scaling up to industrial production [3]. Compare that with what strips already are: most point-of-care glucose tests use disposable, screen-printed enzyme electrode strips, a format that reached the market in the 1980s alongside mediator-based sensors [1].